Endobronchial Ultrasound Biopsy Device Market Size, Share, Competitive Landscape and Trend Analysis Report by Product, by Application and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

Endobronchial ultrasound (EBUS) is primarily used is diagnosis of the progression of lung cancer, its stages and assessment of further possible spread of the diseases to neighbouring body parts including lymph nodes. Endobronchial ultrasound (EBUS) technique has modernized over the time and enables the pulmonologists to sample tissues as well as fluid obtained from lungs and adjacent lymph nodes to visualize the structure surrounding the tracheobronchial tree.  The EBUS and endobronchial ultrasound-assisted transbronchial needle aspiration (EBUS TBNA) are recently developed advanced techniques and show promising results in evaluation of pulmonary nodules, and diagnosis of lung infections. Additionally, endobronchial ultrasound biopsy has applications in identification of various diseases including tuberculosis and chronic pulmonary obstructive disorder that negatively impact the lungs and other respiratory organs. For instance, enlarged lymph nodes and abnormal development of masses in the chest and many others. Endobronchial ultrasound biopsy is a minimally invasive technique for collection of tissue samples, majorly from lungs.

COVID – 19 scenario analysis: 

• The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses
• Industry closures and people are asked to stay in their homes which has cause taken a huge toll in terms of money and economic growth
• Over 4 million people affected globally, with 300 thousand losing their lives due to SARS-CoV-2
• Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers
• Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to for endobronchial ultrasound biopsy has been reduced and this segment have to face negligence subsequently causing negative impact on endobronchial ultrasound biopsy market
• However, the higher prevalence of SARS-CoV-2 virus in people with lung disorders is attributed with higher mortality and morbidity rates, which would soar the demand for endobronchial ultrasound biopsy devices in the market

Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis

The factors including technological development in EBUS devices, consumer preference towards minimally invasive surgeries, growing prevalence of respiratory diseases like tuberculosis and high number of people suffering from lung cancer are driving the global endobronchial ultrasound biopsy market. While low cost of manufacturing in emerging countries is offering new growth avenues to the endobronchial ultrasound biopsy market for expansion in near future. Furthermore, rising geriatric population coupled with higher rates of lung infections and other respiratory ailments requiring endoscopic ultrasound procedures are the factors that fuel the growth of this market.

Certain studies in areas related to lung ailments and respiratory disorders concluded that endobronchial ultrasound is affordable and cost-effective in comparison with other therapies as it reduces the requirement for costly, invasive and highly morbid procedures like mediastinoscopy and thoracotomy. Additionally, EBUS offer better images that provides the physicians and pulmonologists in visualization of several complicated areas and enable more access to these difficult-to-reach areas which helps in efficient diagnosis and biopsy.

On the contrary, endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an advanced technique, but it requires expertise and experience in implementing it effectively. Evidence-based procedures for training the pulmonologists in the area of EBUS-TBNA are necessary, however; as of now, no such accepted or standard techniques exist for assessing EBUS technical skills and competencies which would hamper the growth for this market. In addition to this, the high cost of these medical devices and dearth of proper reimbursement policies in emerging economies can potentially restrain the market.

Increasing patient preference towards minimally invasive surgeries

Endobronchial ultrasound biopsy being a minimally invasive procedure is gaining popularity as an alternative to open surgeries that are invasive in nature, thereby shifting the patient preference towards minimally invasive surgeries owing to certain attributes such as minor incisions, lesser pain, tissue damage, prevention of surgical scars, rapid recovery and lesser stay at the healthcare facilities in comparison with invasive surgeries These techniques being increasingly used across the medical field as they benefit both the medical professionals and patients as they minimize the discomfort caused to patients due to open surgeries and mostly, avoid surgeries and physical harm. The advantages such as minor complications in rare cases, less pain and lower surgery costs pertaining to use of endobronchial ultrasound biopsy is likely to facilitate the market growth over the next few years.

Increasing incidences of lung cancer to propel the growth

Rising incidences of cancers and geriatric population are the factors that go hand-in-hand and are on rise since past few decades. The growth of cancers considering the current growth rate is estimated to have around 27.5 million new cancer cases annually by 2040 around the world. This represents an immense increase of 61.7% from the year 2018 and is further estimated to grow in males with an increasing rate of 67.6 comparatively higher than females estimated to increase at a rate of 55.3%. Additionally, lung cancer being 3rd major cause of cancer in the UK, resulting in 13% of new cases of cancer. Similarly in India, approximately 67,795 new reported cancer cases were seen in 2018. Due to high of cancer, and increasing population base suffering with lung cancer, the demand for endobronchial ultrasound biopsy procedures is expected to surge in the near future, thereby augment the market growth.

 Key benefits of the report:

• This study presents the analytical depiction of the global endobronchial ultrasound biopsy devices market along with the current trends and future estimations to determine the imminent investment pockets.
• The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global endobronchial ultrasound biopsy devices market share.
• The current market is quantitatively analyzed to highlight the global endobronchial ultrasound biopsy devices market growth scenario.
• Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
• The report provides a detailed global endobronchial ultrasound biopsy devices market analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the Endobronchial ultrasound biopsy devices Market research report:

• What are the leading market players active in the endobronchial ultrasound biopsy devices market?
• What the current trends will influence the market in the next few years?
• What are the driving factors, restraints, and opportunities in the market?
• What are the projections for the future that would help in taking further strategic steps?

  Endobronchial Ultrasound Biopsy Device Market Report Highlights

Aspects	Details
By Product	Biopsy Forceps Cytology Brushes Biopsy Needles Transbronchial Aspiration Needles Spray Catheters Others
By Application	Lung Cancer Diagnosis Lung Infection Diagnosis Others
By End User	Hospitals Specialty Cancer Care Centers Diagnostic Centers Ambulatory Surgical Centers
By Region	North America  (U.S., Canada, Mexico) Europe  (Germany, France, Uk, Italy, Spain, Rest of Europe) Asia-Pacific  (Japan, China, India, Australia, South Korea, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players	Veran Medical Technologies, FUJIFILM Corporation, Medi-Globe Corporation, Boston Scientific Corporation, Medtronic plc, Clinodevice, CONMED Corporation, Cook Group Incorporated., Simbionix USA Corporation, Olympus Corporation
Other Players	Siemens Healthcare